Glucose Meter Market Size, Share, Growth, and Industry Analysis, By Technology (Glucose Oxidase Method, Glucose Dehydrogenase Method, and Other Type) By Application (Medical, and Home Care), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

GLUCOSE METER MARKET REPORT OVERVIEW

The global glucose meter market was valued at USD 1.55 billion in 2024 and is expected to grow to USD 1.65 billion in 2025, reaching USD 2.69 billion by 2033, with a projected CAGR of 6.3% from 2025 to 2033.

A glucose meter, also referred to as a glucometer, is a medical tool used to estimate the blood glucose level. A strip of glucose paper dipped in something else and measured against the glucose chart is another option. It is a crucial component of home blood glucose monitoring (HBGM) used by people with hypoglycemia or diabetes mellitus. A lancet is used to prick the skin, and a small amount of blood is placed on a disposable test strip, which the meter reads and uses to determine the blood glucose level. Following that, the meter shows the reading in mg/dl or mmol/l. Since around 1980, achieving closer-to-normal blood glucose levels for as much of the time as possible, guided by HBGM several times a day, has been a primary goal of the management of type 1 diabetes and type 2 diabetes mellitus. The advantages include a decrease in the frequency and severity of hyperglycemia-related long-term complications as well as a decrease in the short-term, potentially fatal effects of hypoglycemia. Monitoring blood glucose levels can help manage diabetes and lower the long-term risk of complications. It is advisable to own a glucometer because it is useful for determining whether the blood glucose level is normal, low, or high. For those who want to regularly check their blood glucose levels in a painless, simple, and comfortable manner, glucometers are perfect. One can adjust their diet or way of life as necessary based on the findings.

Various applications of glucose meter includes in medical, homecare, etc. Monthly launches of new products in the field, and the rising government spending  on the healthcare systems are some of the major driving factors of the market. Apart from all the usages of glucose meter, there are also some slight disadvantages of using the same. The time consumption of glucose oxidase method is one among those restraints of the market.

COVID-19 IMPACT

Increased Lifestyle Diseases During COVID-19 to Drive the Market

The COVID-19 pandemic has expanded the market for glucose meter equipment and increased demand for these products among diabetics. Due to the pandemic's emphasis on the use of virtual clinics and telemedicine for diabetic management, consumer awareness of the advantages of blood glucose monitoring devices increased. The use of blood glucose monitoring devices by patients and healthcare professionals improved glycemic control and may have increased patient autonomy, significantly altering diabetes care. Additionally, a rise in demand for blood glucose monitoring devices as a result of major market players responding quickly to the COVID-19 pandemic.

LATEST TRENDS

Changing Lifestyle Resulting in Diseases to Drive the Market

Obesity is rising globally as a result of changing lifestyles, rising alcohol consumption, physical inactivity, and unhealthy eating patterns. Glucose meter sales have sharply increased as a result of the exponential rise in the number of obese people. Obesity causes fat tissues to release more fat molecules into the blood, which affects insulin-responsive cells and lowers their sensitivity to insulin, which in turn leads to diabetes.

Request a Free sample to learn more about this report

GLUCOSE METER MARKET SEGMENTATION

By Type

The market is classified into glucose oxidase method, glucose dehydrogenase method, and other type based on technology. The glucose oxidase method segment will lead the glucose meter market share throughout the forecast period.

By Application

The market is classified into medical, and home care on the basis of application. The medical segment will lead the glucose meter market share throughout the forecast period.

DRIVING FACTORS

Rise in the Number of New Product Launches to Drive the Market

The glucose meter market growth is anticipated to be fueled by the development of continuous glucose monitoring systems, in which a sensor implanted under the skin provides continuous glucose measurements for regular intervals of time. With multiple daily insulin dosages, continuous glucose monitoring (CGM) has shown clinical benefits for patients with type 2 diabetes. Due to their ease of use and continuous blood glucose monitoring, wearable continuous blood glucose monitors are expected to increase demand for glucose meters. During the anticipated period, these factors are anticipated to drive market revenue.

Increasing Government Funding in Healthcare to Drive the Market

The government's increased funding will likely accelerate market growth. Additionally, the development and expansion of the healthcare sector, driven by both public and private actors, particularly in developing economies, will open up lucrative opportunities for glucose meter market expansion. The introduction of technologically advanced products in hospitals, rising investment in the development of advanced medical products and devices, and an increasing geriatric population base also have a positive impact on the market growth rate.

RESTRAINING FACTORS

Time Consumption of Glucose Oxidase Method to Restrain the Market

The main restraining factor of the market is that the glucose oxidase method, which is the most demanded mode of glucose meter technology type, takes a lot of time and effort. Glucose oxidase method is frequently used for a variety of functions, including the removal of glucose or oxygen from the medium and the production of controlled peroxide or gluconic acid. The development of glucose biosensors also frequently makes use of it.

• Request a Free sample to learn more about this report

•  

GLUCOSE METER MARKET REGIONAL INSIGHTS

North America to Hold the Largest Market Share Owing to the Well-Established Health System

North America holds the largest share of the glucose meter market. Since its healthcare system is well-established, North America dominated the market. The regional market is also anticipated to be driven by the rising prevalence of obesity, high treatment costs, technological advancements, and new product launches. The market is also being driven by rising patient populations with diabetes and rising demand and adoption of new and innovative wearable and continuous glucose meters in this region.

After North America, Asia Pacific is expected to hold the second largest share. Due to rising patient awareness, increased glucose monitoring adoption, and rising per capita healthcare spending in the region, Asia Pacific is predicted to have the highest CAGR.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage  

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

List of Top Glucose Meter Companies

• Roche (Switzerland)
• Johnson & Johnson (U.S.)
• Abbott (U.S.)
• Ascensia (Switzerland)
• ARKRAY (Japan)
• I-SENS (South Korea)
• OMRON (Japan)
• B. Braun Medical (Germany)
• 77 Elektronika (Hungary)
• AgaMatrix (U.S.)
• ALL Medicus (South Korea)
• Terumo Corporation (Japan)
• Sinocare (China)
• Beijing Yicheng (China)
• Yuyue Group (China)
• ACON Laboratories (U.S.)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.